BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 16681730)

  • 1. Investigation of human papillomavirus by hybrid capture II in cervical carcinomas including 113 adenocarcinomas and related lesions.
    Moreira MA; Longato-Filho A; Taromaru E; Queiroz G; Jubé LF; Pinto SA; Schmitt FC
    Int J Gynecol Cancer; 2006; 16(2):586-90. PubMed ID: 16681730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction.
    Iwasawa A; Nieminen P; Lehtinen M; Paavonen J
    Cancer; 1996 Jun; 77(11):2275-9. PubMed ID: 8635095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
    Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
    Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus and mixed epithelial tumors of the endometrium.
    O'Leary JJ; Landers RJ; Crowley M; Healy I; O'Donovan M; Healy V; Kealy WF; Hogan J; Doyle CT
    Hum Pathol; 1998 Apr; 29(4):383-9. PubMed ID: 9563789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis.
    Rodríguez-Carunchio L; Soveral I; Steenbergen RD; Torné A; Martinez S; Fusté P; Pahisa J; Marimon L; Ordi J; del Pino M
    BJOG; 2015 Jan; 122(1):119-27. PubMed ID: 25229645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent detection of human papilloma viruses in cervical dysplasia by PCR single-strand DNA-conformational polymorphism analysis.
    Nakagawa H; Sugano K; Fujii T; Kubushiro K; Tsukazaki K; Nozawa S
    Anticancer Res; 2002; 22(3):1655-60. PubMed ID: 12168850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Contribution of high risk human papillomavirus testing to the management of premalignant and malignant lesions of the uterine cervix].
    Ordi J; Puig-Tintoré LM; Torné A; Sanz S; Esteve R; Romagosa C; Cardesa A
    Med Clin (Barc); 2003 Oct; 121(12):441-5. PubMed ID: 14572367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix.
    Burk RD; Terai M; Gravitt PE; Brinton LA; Kurman RJ; Barnes WA; Greenberg MD; Hadjimichael OC; Fu L; McGowan L; Mortel R; Schwartz PE; Hildesheim A
    Cancer Res; 2003 Nov; 63(21):7215-20. PubMed ID: 14612516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus DNA detection in cervical specimens by hybrid capture: correlation with cytologic and histologic diagnoses of squamous intraepithelial lesions of the cervix.
    Hall S; Lörincz A; Shah F; Sherman ME; Abbas F; Paull G; Kurman RJ; Shah KV
    Gynecol Oncol; 1996 Sep; 62(3):353-9. PubMed ID: 8812532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical screening test results associated with 265 histopathologic diagnoses of cervical glandular neoplasia.
    Zhao C; Li Z; Austin RM
    Am J Clin Pathol; 2013 Jul; 140(1):47-54. PubMed ID: 23765533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus localization in cervical adenocarcinoma and adenosquamous carcinoma using in situ polymerase chain reaction: review of the literature of human papillomavirus detection in these carcinomas.
    Ogura K; Ishi K; Matsumoto T; Kina K; Nojima M; Suda K
    Pathol Int; 2006 Jun; 56(6):301-8. PubMed ID: 16704493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-risk human papillomavirus DNA testing: a marker for atypical glandular cells.
    Saqi A; Gupta PK; Erroll M; Babiac A; Blackmun D; Mansukhani M; Vazquez M
    Diagn Cytopathol; 2006 Mar; 34(3):235-9. PubMed ID: 16470857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
    Miller RA; Mody DR; Tams KC; Thrall MJ
    Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple HPV genotypes in cervical carcinomas: improved DNA detection and typing in archival tissues.
    Huang LW; Chao SL; Chen PH; Chou HP
    J Clin Virol; 2004 Apr; 29(4):271-6. PubMed ID: 15018855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glandular lesions of the uterine cervix: prognostic implications of human papillomavirus status.
    Anciaux D; Lawrence WD; Gregoire L
    Int J Gynecol Pathol; 1997 Apr; 16(2):103-10. PubMed ID: 9100062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The distribution of human papillomavirus genotypes in cervical cancer and intraepithelial neoplasia lesions among Chinese women in Yunnan Province.
    Yuanyue L; Baloch Z; Yasmeen N; Tao Y; Xiaomei W; Xueshan X
    J Infect Public Health; 2018; 11(1):105-110. PubMed ID: 28697900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV DNA testing of the residual sample of liquid-based Pap test: utility as a quality assurance monitor.
    Zuna RE; Moore W; Dunn ST
    Mod Pathol; 2001 Mar; 14(3):147-51. PubMed ID: 11266518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of p16INK4A overexpression with human papillomavirus infection in cervical adenocarcinomas.
    Ishikawa M; Fujii T; Masumoto N; Saito M; Mukai M; Nindl I; Ridder R; Fukuchi T; Kubushiro K; Tsukazaki K; Nozawa S
    Int J Gynecol Pathol; 2003 Oct; 22(4):378-85. PubMed ID: 14501820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
    Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
    Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.